openPR Logo
Press release

Home Diagnostics Market Growth to be Fuelled by 2018 to 2026(Market Dynamics:-rivers,Restraints,Trends)

07-05-2019 02:08 PM CET | Advertising, Media Consulting, Marketing Research

Press release from: Fact.MR

/ PR Agency: Fact.MR
Home Diagnostics Market Growth to be Fuelled by 2018

Fact.MR, in its latest market study, opines that the home diagnostics market will grow at a healthy 3.5% value CAGR, surpassing US$ 6.3 million by 2026. According to the report, sales will remain buoyant in developed regions, with North America and Europe collectively accounting for over 50% revenue share of the market. The Fact.MR study remains bullish on the prospects of home diagnostics market players in developing countries, as growing focus on health & wellness, and emergence of many Asian countries as medical tourism hubs creates opportunities.

Increasing preference for self-diagnosis continues to be a trigger for home diagnostics sales, whereas a combination of industry-specific and regulatory factors continue to influence the strategies of market players. Governing bodies such as the U.S. Food and Drug Administration (FDA) and the European Commission regulate home diagnostics with stringent quality control regulations and labeling requirements. Gaining EU CE mark, FDA 510(k) clearance, and FDA approved Premarket Approval Application (PMA) continues to be a primary focus for home diagnostics manufacturers who are looking to scale up their presence in developed markets. For instance, Abbott Laboratories, a leading pharmaceutical company in the U.S., recently got an FDA approval for marketing its FreeStyle® Libre 14 day Flash Glucose Monitoring system in the U.S. ACON Laboratories, another prominent player in the home diagnostics market announced that it has received FDA clearance of Mission® U120 urine reagent strips. According to the report, compliance to ever-evolving regulations and gaining regulatory approval remains both an opportunity and challenge for market players.

Request Sample Report- https://www.factmr.com/connectus/sample?flag=S&rep_id=1892

The report also finds that home diagnostics manufacturers are focusing on incorporating advanced technology to differentiate their offerings in the market. For example, Abbott Laboratories adopted next-generation sensor technologies to upgrade its FreeStyle Libre system (10 day) to the FreeStyle® Libre 14 day Flash Glucose Monitoring system with improved accuracy and better mean absolute relative difference.

The Fact.MR study finds that glucose monitoring devices will continue to witness robust demand and dominate the home diagnostics market with over than 80% revenue share in the market. According to the World Health Organization (WHO), the number of people suffering from diabetes reached 422 million in 2014, and it will soon become a leading cause of death. Increasing prevalence of diabetes worldwide and the growing need for monitoring sugar levels among diabetes patients is likely to boost adoption of glucose monitoring devices during the assessment period. Home diagnostics market players are aware of the surging demand for glucose monitoring devices, and are focusing on increasing their product portfolio in this segment. The other lucrative segments in the home diagnostics market include pregnancy tests and ovulation prediction kits.

Home Diagnostics Market Research Report Overview- https://www.factmr.com/report/1892/home-diagnostics-market

According to the report, although demand for home diagnostics is concentrated in developed countries, home diagnostics market players are putting efforts to boost uptake in developing regions. According to statistics published by WHO, the prevalence of diabetes has been the highest in middle and low-income countries.

Anticipating the burgeoning demand for glucose monitoring devices in emerging Asia, players in the home diagnostics market are shifting their focus towards developing nations, including China and India. ARKRAY, Inc. – a Japanese manufacturer in the home diagnostics market – recently announced that it will strengthen its diabetes testing instrument production capacity in China. Leading manufacturers in the home diagnostics market are modifying their marketing strategies to improve awareness about cost-effective and efficient home diagnostics to leverage lucrative opportunities in the Asia-Pacific region.

Request Methodology- https://www.factmr.com/connectus/sample?flag=RM&rep_id=1892

Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/

About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Home Diagnostics Market Growth to be Fuelled by 2018 to 2026(Market Dynamics:-rivers,Restraints,Trends) here

News-ID: 1797834 • Views:

More Releases from Fact.MR

Thermal Management Materials Market Forecast to Reach USD 7.96 Billion by 2035, Driven by 6.3% CAGR
Thermal Management Materials Market Forecast to Reach USD 7.96 Billion by 2035, …
The global thermal management materials market is projected to reach USD 7.96 billion by 2035, recording an absolute increase of USD 3.64 billion over the forecast period. Valued at USD 4.32 billion in 2025, the market is set to rise at a CAGR of 6.3% during the assessment period. The overall market size is expected to grow by nearly 1.8 times during the same period, supported by increasing heat dissipation
Polyolefin Market Forecast 2026-2036: Market to Reach USD 470.5 Billion by 2036
Polyolefin Market Forecast 2026-2036: Market to Reach USD 470.5 Billion by 2036
The global polyolefin market is projected to reach a valuation of USD 470.5 billion by 2036, rising from USD 274.4 billion in 2025. This expansion represents a steady CAGR of 5.5% during the forecast period, fueled by increasing demand for lightweight, durable polymer materials across global packaging and automotive industries. Get Access Report Sample : https://www.factmr.com/connectus/sample?flag=S&rep_id=12056 Polyolefin Market Outlook What is the polyolefin market size in 2026? The source data provides values
Helium Market Forecast 2026-2036: Market Poised to Reach USD 8.5 Billion by 2035
Helium Market Forecast 2026-2036: Market Poised to Reach USD 8.5 Billion by 2035
The global helium market is projected to grow from USD 4.4 billion in 2025 to USD 8.5 billion by 2035, exhibiting a robust CAGR of 6.8%. This expansion represents a significant absolute increase of USD 4.1 billion over the forecast period, driven by critical demand across healthcare, electronics, and aerospace sectors worldwide. Get Access Report Sample : https://www.factmr.com/connectus/sample?flag=S&rep_id=12073 Helium Market Outlook What is the market value in 2025? USD 4.4 billion. What is the
Rare Earth Elements Market Forecast 2026-2036: Market to Reach USD 9.7 Billion by 2035,
Rare Earth Elements Market Forecast 2026-2036: Market to Reach USD 9.7 Billion b …
The global rare earth elements market is projected to grow from USD 4.2 billion in 2025 to USD 9.7 billion by 2035, exhibiting a CAGR of 8.7% over the forecast period. This significant expansion, representing a 2.3 times increase in market value, is propelled by intensifying demand for critical materials in electric vehicle (EV) manufacturing and renewable energy infrastructure. Get Access Report Sample : https://www.factmr.com/connectus/sample?flag=S&rep_id=12141 Rare Earth Elements Market What is the

All 5 Releases


More Releases for FDA

DreaMed receives 5th FDA Clearance
TEL AVIV, Israel: DreaMed Diabetes LTD. ("DreaMed" or the "Company"), developer of the endo.digital Clinical Decision Support System announced today that it has received its 5th U.S Food and Drug Administration (FDA) clearance that expands the scope of AI enhanced treatment recommendations to patients on fixed meal insulin regimens. endo.digital is the first decision support system that has been cleared to assist healthcare providers in the management of diabetes
FDA Compliant Blood Storage and Preservation
Accsense Monitoring System Automates Data Archive and Alarming CAS DataLoggers provided the temperature alarming and monitoring system to a hospital blood bank looking to replace their old paper chart recorders as they became unreliable and spare parts were harder to find. For proper blood storage and preservation, the lab’s medical units needed to maintain storage temperatures between 2°C to 6°C (36°F to 43°F), given the perishability of blood components. The facility
FDA grants orphan drug status to Vicore
US Food and Drug Administration has awarded Vicore Pharmaceuticals with orphan Drug designation for the treatment of Idiopathic Pulmonary Fibrosis (IPF). FDA’s Orphan Drug Designation program provides certain incentives for companies developing therapeutics to treat rare diseases or conditions, defined as those affecting less than 200,000 individuals in the U.S. A drug candidate and its sponsor must meet several key criteria in order to qualify for, and obtain, orphan drug
New FDA Design Control Training Courses
Salt Lake City, Utah - February 23 2017 - Procenius Consulting is a medical device consulting firm specializing solely in medical device design controls regulation (21 CFR 820.30). Announcing New Design Control Training Courses Procenius Consulting has just launched two new training courses covering basic and advanced topics of medical device design control regulation. These courses focus on compliance, practical implementation and industry best practices techniques for developing or improving a
fda online training
GRC Training Solutions provides end-to-end FDA compliance solutions for those companies who want to maximize security, minimize operational costs, improve staff productivity and stay on top of all their compliance documentation. GRC Training Solutions boasts a team of experts and specialists who have a proven track record in working with the biotechnology, medical device, diagnostic and pharmaceutical fields. Our team will work with you closely and develop solutions that meet
11-09-2016 | Science & Education
GRCTS
FDA online training
Description: Device firms, establishments or facilities that are involved in the production and distribution of medical devices intended for use in the U.S are required to register annually. Most establishments that are required to register with the FDA are also required to list the devices that are made there and the activities that are performed on those devices. Initially, FDA issued a 28-page Proposed Rule that would amend its regulations regarding